T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion

Cancer Research

Volumn 72, Issue 21, 2012, Pages 5473-5482

  Hindley, James P ^a   Jones, Emma ^a   Smart, Kathryn ^a   Bridgeman, Hayley ^a   Lauder, Sarah N ^a   Ondondo, Beatrice ^a   Cutting, Scott ^a   Ladell, Kristin ^a   Wynn, Katherine K ^a   Withers, David ^b   Price, David A ^a   Ager, Ann ^a   Godkin, Andrew J ^a   Gallimore, Awen M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CONTROL; CANCER IMMUNOTHERAPY; CELL ACTIVITY; CELL FUNCTION; CELL MIGRATION; ENDOTHELIUM CELL; FIBROSARCOMA; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; TUMOR GROWTH; VENULE;

ANIMALS; CELL PROLIFERATION; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; VENULES;

EID: 84868262136     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-1912     Document Type: Article

References (33)

1. Gallimore A, Godkin A. Regulatory T cells and tumour immunity \- observations in mice and men. Immunology 2008;123:157-63.
2. Betts G, Twohig J, Van den Broek M, Sierro S, Godkin A, Gallimore A. Theimpact of regulatory Tcells on carcinogen-induced sarcogenesis. Br J Cancer 2007;96:1849-54.
3. +Tcells: acommon basis between tumorimmu-nity and autoimmunity. J Immunol 1999;163:5211-8.
4. Sutmuller RP, van Duivenvoorde LM, van Elsas A, Schumacher TN, Wildenberg ME, Allison JP, et al.Synergism of cytotoxic Tlymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cellsinantitumortherapyrevealsalternativepathwaysforsuppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001; 194:823-32.
5. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophicautoimmunitythroughoutthelifespanof mice. Nat Immu-nol 2007;8:191-7.
6. Quezada SA, Peggs KS, Simpson TR, Shen Y, Littman DR, Allison JP. Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma. J Exp Med 2008;205:2125-38.
7. + regulatory T cells improves effectivetherapeuticvaccination against established melanoma. Can-cer Res 2010;70:7788-99.
8. Teng MW, Ngiow SF, von Scheidt B, Mc Laughlin N, Sparwasser T, Smyth MJ. Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth. Cancer Res 2010;70:7800-9.
9. Drayton DL, Liao S, Mounzer RH, Ruddle NH. Lymphoid organ devel-opment: from ontogeny to neogenesis. Nat Immunol 2006;7:344-53.
10. Schrama D, thor Straten P, Fischer WH, Mc Lellan AD, Brocker EB, Reisfeld RA, et al. Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue. Immunity 2001;14:111-21.
11. Hindley JP, Ferreira C, Jones E, Lauder SN, Ladell K, Wynn KK, et al. Analysisofthe T-cell receptor repertoires of tumor-infiltratingconven-tional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors. Cancer Res 2011;71:736-46.
12. Streeter PR, Rouse BT, Butcher EC Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte hom-ing into peripheral lymph nodes. J Cell Biol 1988;107:1853-62.
13. Banks TA, Rouse BT, Kerley MK, Blair PJ, Godfrey VL, Kuklin NA, et al. Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J Immunol 1995;155:1685-93.
14. Cyster JG. Lymphoid organ developmentand cell migration. Immunol Rev 2003; 195:5-14.
15. De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S, et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994;264:703-7.
16. Bistrup A, Tsay D, Shenoy P, Singer MS, Bangia N, Luther SA, et al. Detection of a sulfotransferase (HEC-Glc NAc6ST) in high endothelial venules of lymph nodes and in high endothelial venule-like vessels with in ectopic lymphoid aggregates: relationship to the MECA-79 epitope. Am J Pathol 2004;164:1635-44.
17. Pablos JL, Santiago B, Tsay D, Singer MS, Palao G, Galindo M, et al. A HEV-restricted sulfotransferase is expressed in rheumatoid arthritis synoviumand isinduced by lymphotoxin-alpha/betaand TNF-alpha in cultured endothelial cells. BMC Immunol 2005;6:6.
18. Cupedo T, Mebius RE. Cellular interactions in lymph node develop-ment. J Immunol 2005;174:21-5.
19. Finke D. Fateand function oflymphoidtissue inducercells. Curr Opin Immunol 2005;17:144-50.
20. Kim S, Han S, Withers DR, Gaspal F, Bae J, Baik S, et al.CD117(+)CD3 (-) CD56(-) OX40L high cells express IL-22 and display an LTi pheno-type in human secondary lymphoid tissues. Eur J Immunol 2011; 41:1563-72.
21. Ley K, Kansas GS. Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat Rev Immunol 2004;4:325-35.
22. Rosen SD. Ligandsfor L-selectin: homing, inflammation, and beyond. Annu Rev Immunol 2004;22:129-56.
23. Ganss R, Ryschich E, Klar E, Arnold B, Hammerling GJ. Combination of T-cell therapy and triggerof inflammation induces remodeling of the vasculature and tumor eradication. Cancer Res 2002;62:1462-70.
24. Browning JL, Allaire N, Ngam-Ek A, Notidis E, Hunt J, Perrin S, et al. Lymphotoxin-beta receptorsignaling is required forthe homeostatic control of HEVdifferentiation and function. Immunity 2005;23:539-50.
25. Moussion C, Girard JP. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature 2011;479: 542-6.
26. Martinet L, Garrido I, Filleron T, Le Guellec S, Bellard E, Fournie JJ, et al. Human solid tumorscontain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res 2011;71:5678-87.
27. Okayama H, Kumamoto K, Saitou K, Hayase S, Kofunato Y, Sato Y, et al. Ectopic expression of MECA-79 as a novel prognostic indicator in gastric cancer. Cancer Sci 2011;102:1088-94.
28. Steere AC, Duray PH, Butcher EC Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis. Comparison with rheumatoid synovium and tonsillar lymphoid tissue. Arthritis Rheum 1988;31: 487-95.
29. Houtkamp MA, de Boer OJ, van der Loos CM, van der Wal AC, Becker AE. Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral mmune responses. J Pathol 2001;193:263-9.
30. Shomer NH, Fox JG, Juedes AE, Ruddle NH. Helicobacter-induced chronic active lymphoid aggregates have characteristics of tertiary lymphoid tissue. Infect Immun 2003;71:3572-7.
31. Thaunat O, Field AC, Dai J, Louedec L, Patey N, Bloch MF, et al. Lymphoidneogenesisinchronicrejection:evidenceforalocalhumoral alloimmune response. Proc Natl Acad Sci U S A 2005;102:14723-8.
32. Matsushita H, Vesely MD, Koboldt DC, Rickert CG, Uppaluri R, Magrini VJ, et al. Cancer exome analysis reveals a T-cell-dependent mecha-nism of cancer immunoediting. Nature 2012;482:400-4.
33. Yu P, Lee Y, Liu W, Chin RK, Wang J, Wang Y, et al. Priming of naive T cells inside tumors leads to eradication of established tumors. Nat Immunol 2004;5:141-9.